The current issue of CEJU brings a somewhat ambiguous paper entitled “Vitamin D and urological cancers” describing (possible) role of the vit. D in the etiology of urological cancers [1]. Indeed, last years brought numerous publications presenting that 1,25-dihydroxyvitamin D3 may alter human susceptibility to different diseases (even improve fitness) and its capability to cure or, at least, to soothe some humancancers [2, 3, 4]. Such contribution of the vit. D has been debated widely elsewhere, became trendy in contemporary medicine and engaged a great number of researches. VitD and polymorphism of its targeted receptors have been harnessed to the etiology of: hypertension, bronchial asthma, type 2 diabetes mellitus, autoimmune disorders, cognitive decline and so forth [5]. Some studies suggest that vit. D receptor polymorphism may play a role in the prostate cancer, bladder cancer and other malicious tumours [6, 7]. Its role in the progress of the colon cancer has been scientifically proven [6]. The evidence for a protective effect of vitamin D on the risk of breast cancer has been published before. Thus, it looked that medicine found a gorgeous but simple and attainable remedy for almost everything.Paper under discussion keeps pace with that papers and I am convinced that is worthy of notice as a well-tailored analysis adding a new twist to that issue [1].Although considerable progress has been made toward understanding tumours etiology and the role of vit. D in human pathology, its role in cancer is still unclear [8, 9], Some papers present conflicting data clearly demonstrated in the manuscript under debate. Authors performed a survey of eligible studies on above mentioned possible association [1]. Its real scientific merit consist in concentration of a large group of data – it is an undisputed value of that paper.Apparently, pinning high hopes on the vitD is a risky business. A consultative committee – US Preventive Services Task Force concluded that all these data are insufficient [10]. Probably other factors that contribute to overall good health status, like healthy lifestyle with befitting physical activity, keeping healthy and balanced diet may intermingle with vitD level. In the light of that it is possible that some trials confused causes and effects. Well, a distinction should be made between the primary and secondary outcome but we do not confidently know which came first: the chicken or the egg? Moreover, next trials questioned the validity of before published research.A large volume meta-analysis (290 prospective observational studies and 172 random trials) indeed confirmed inversely proportional interrelation of the level of vit. D and incidence of cardiovascular, metabolic, inflammatory, neurologic and psychiatric disorders (even Alzheimer disease) but could not indicate the primary cause and secondary effect. Also, another authors found that vit. D supplementation had at most insignificant therapeutic effect on the above conditions [11].It is apparent that the existing evidence to guide us on the subject of the vit. D supplementation is vague and volatile and is based on conflicting data. Nevertheless, there is one certain axiom that have emerged from above citations: complying with balanced, sagacious and healthy life style undoubtedly helps to keep vit. D and the risk of numerous diseases on a safe level.
Authors: Irene M Shui; Lorelei A Mucci; Peter Kraft; Rulla M Tamimi; Sara Lindstrom; Kathryn L Penney; Katharina Nimptsch; Bruce W Hollis; Natalie Dupre; Elizabeth A Platz; Meir J Stampfer; Edward Giovannucci Journal: J Natl Cancer Inst Date: 2012-04-12 Impact factor: 13.506
Authors: Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney Journal: Am J Clin Nutr Date: 2007-06 Impact factor: 7.045
Authors: Carsten Carlberg; Sabine Seuter; Vanessa D F de Mello; Ursula Schwab; Sari Voutilainen; Kari Pulkki; Tarja Nurmi; Jyrki Virtanen; Tomi-Pekka Tuomainen; Matti Uusitupa Journal: PLoS One Date: 2013-07-29 Impact factor: 3.240
Authors: Hannah Arem; Kai Yu; Xiaoqin Xiong; Kristin Moy; Neal D Freedman; Susan T Mayne; Demetrius Albanes; Alan A Arslan; Melissa Austin; William R Bamlet; Laura Beane-Freeman; Paige Bracci; Federico Canzian; Michelle Cotterchio; Eric J Duell; Steve Gallinger; Graham G Giles; Michael Goggins; Phyllis J Goodman; Patricia Hartge; Manal Hassan; Kathy Helzlsouer; Brian Henderson; Elizabeth A Holly; Robert Hoover; Eric J Jacobs; Aruna Kamineni; Alison Klein; Eric Klein; Laurence N Kolonel; Donghui Li; Núria Malats; Satu Männistö; Marjorie L McCullough; Sara H Olson; Irene Orlow; Ulrike Peters; Gloria M Petersen; Miquel Porta; Gianluca Severi; Xiao-Ou Shu; Kala Visvanathan; Emily White; Herbert Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Geoffrey S Tobias; Dennis Maeder; Michelle Brotzman; Harvey Risch; Joshua N Sampson; Rachael Z Stolzenberg-Solomon Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240
Authors: Sharon L McDonnell; Carole Baggerly; Christine B French; Leo L Baggerly; Cedric F Garland; Edward D Gorham; Joan M Lappe; Robert P Heaney Journal: PLoS One Date: 2016-04-06 Impact factor: 3.240